硕腾

Zoetis Bollinger Bands Narrowing, KDJ Death Cross on 15-minute chart.

Zoetis 15min chart Bollinger Bands expanding downward, KDJ death cross confirmed.

Zoetis: BTIG Reiterates Buy Rating, Raises PT to $160 from $160.

Zoetis stock price triggers Bollinger Bands Narrowing and KDJ Death Cross.

Zoetis

Zoetis Inc. R&D Pipeline Progress and Strategic Vision in Animal Health Innovation

Catalyst<ul> <li>Most analysts rate ZTS Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Bearish signals are obviously dominant in technical indicators pointing to uncertainty in market direction.</li> <li>Net outflow trends across all order sizes indicate declining investor confidence in ZTS.</li></ul>

Key Factors

Zoetis (ZTS) shares declined 2.48% amid EU approval of Lenivia for canine osteoarthritis pain and ongoing market skepticism. BTIG reiterates a Buy rating for Zoetis (ZTS) with a $160 price target, despite broader analyst caution and price target reductions. Zoetis (ZTS) CEO Kristin Peck announced strategic R&D progress and leadership changes, including Dr. Kevin Esch taking over the R&D organization.

ZTS News